Effects of Salvia Miltiorrhiza Tablets

Apr 11, 2022 Source: Cainiu Health
Dr. Liu Zhengxin
Introduction
Not only does Salvia miltiorrhiza (Danshen) promote blood circulation and resolve blood stasis, but it also nourishes the blood. Consequently, Danshen exerts effects of promoting blood circulation, resolving blood stasis, and vasodilation—thereby enhancing myocardial contractility, improving cardiac function, and dilating blood vessels. These actions help prevent and treat atherosclerosis, particularly coronary artery disease. Moreover, Danshen delays cellular oxidation and aging.

The primary active ingredient in Salvia miltiorrhiza tablets is *Salvia miltiorrhiza* (Danshen), the dried root of the plant *Salvia miltiorrhiza* Bunge, belonging to the Lamiaceae family. It is mainly cultivated in Sichuan, Anhui, Jiangsu, Hebei, and Shandong provinces. Harvested in autumn, the roots are cleaned of stems, leaves, and soil, moistened until pliable, sliced, and then sun-dried. Danshen has a bitter taste and a slightly cold nature. In Traditional Chinese Medicine (TCM), it is regarded as having effects comparable to those of the “Four-Ingredient Decoction” (Si Wu Tang). What are the therapeutic actions of Salvia miltiorrhiza tablets?

Therapeutic Actions of Salvia Miltiorrhiza Tablets

These tablets not only promote blood circulation and resolve blood stasis but also nourish the blood. Consequently, Danshen exerts effects including promoting blood circulation, resolving stasis, and dilating blood vessels—thereby enhancing myocardial contractility, improving cardiac function, and preventing or mitigating arteriosclerosis, especially coronary artery disease. Furthermore, Danshen delays cellular oxidation and aging. Modern research has revealed that certain bioactive constituents in Danshen can enhance cellular activity and exert antagonistic effects against mechanisms underlying human aging.

Danshen may affect renal function by stimulating potassium ion secretion from the cortical portion of the renal tubules. Excessive potassium secretion by the kidneys leads to increased urinary potassium excretion and subsequent hypokalemia. Thus, prolonged use may easily result in potassium deficiency, manifesting as generalized fatigue and muscle aches.

Long-term use is not recommended. If symptoms improve, patients should seek medical evaluation promptly and, with their physician’s approval, discontinue the medication or reduce the dosage. Self-extension of treatment duration must be avoided. We hope this information is helpful to you.